CERo Therapeutics Holdings Inc (CERO)
0.3799
+0.02
(+5.65%)
USD |
NASDAQ |
Jun 14, 16:00
0.35
-0.03
(-7.87%)
Pre-Market: 20:00
CERo Therapeutics Holdings Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 0.0052M |
Date | Value |
---|---|
March 31, 2022 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2022
0.0052M
Maximum
Mar 2023
0.0026M
Average
0.0026M
Median
Cash from Financing (Quarterly) Benchmarks
Avalo Therapeutics Inc | 108.61M |
Nutriband Inc | 8.695M |
Kodiak Sciences Inc | 0.038M |
The Oncology Institute Inc | -0.938M |
CEL-SCI Corp | 6.596M |